Explore the new AI foundation model by Insilico Medicine and Liquid AI for efficient pharmaceutical research on private ...

LG CNS is rapidly expanding its AI Transformation (AX) business for enterprises into the pharmaceutical, biotech, and digital ...

The term 'patient centricity' has undergone a radical evolution over recent years. It is no longer a buzzword relegated to corporate social responsibility reports; it has become a fundamental metric ...

TrumpRX and DTC sales may expand prescription drug access, but they will not solve the affordability crisis by themselves.

With various challenges impacting the clinical supply chain, existing models are no longer fit-for-purpose and need to adapt.

Liquid AI and Insilico Medicine today announced a partnership that creates lightweight scientific foundation models for ...

Series C proceeds position Spectris for pivotal top-line data, regulatory submission, and launch planning ahead of a targeted ...

As nonprofit-governed Servier continues to make gains with its IDH-mutant glioma med Voranigo, the drugmaker is wading deeper into the rare oncology arena with a new M&A play.  | Servier on Friday ...

The pharmaceutical industry is racing to turn its data into scientific intelligence with AI. Now, it’s possible to connect your data and tool ecosystem. There is a gold rush happening in ...

Dubey’s argument is that India’s hospital experience today is broken due to crowded outpatient departments (OPDs), long waits, opaque billing and low trust arising from one underlying issue: the cost ...

Single 2.6B-parameter model achieves state-of-the-art performance across drug discovery benchmarks while running entirely on ...

Cash and Investments -- $301.8 million as of December 31, 2025, sufficient to fully fund current Phase III HCV and new HEV programs through 2027. Phase III HCV Trials -- C BEYOND enrollment completed ...